Ameriprise’s Theravance Biopharma TBPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-63,731
| Closed | -$569K | – | 4074 |
|
2025
Q1 | $569K | Sell |
63,731
-37,076
| -37% | -$331K | ﹤0.01% | 3406 |
|
2024
Q4 | $949K | Sell |
100,807
-10,825
| -10% | -$102K | ﹤0.01% | 3233 |
|
2024
Q3 | $900K | Buy |
111,632
+250
| +0.2% | +$2.02K | ﹤0.01% | 3254 |
|
2024
Q2 | $945K | Sell |
111,382
-390
| -0.3% | -$3.31K | ﹤0.01% | 3178 |
|
2024
Q1 | $1M | Buy |
111,772
+78,393
| +235% | +$703K | ﹤0.01% | 3168 |
|
2023
Q4 | $375K | Buy |
+33,379
| New | +$375K | ﹤0.01% | 3551 |
|
2023
Q2 | – | Sell |
-17,030
| Closed | -$185K | – | 3996 |
|
2023
Q1 | $185K | Buy |
17,030
+600
| +4% | +$6.51K | ﹤0.01% | 3741 |
|
2022
Q4 | $185K | Buy |
+16,430
| New | +$185K | ﹤0.01% | 3722 |
|
2021
Q3 | – | Sell |
-11,310
| Closed | -$164K | – | 3953 |
|
2021
Q2 | $164K | Sell |
11,310
-4,121
| -27% | -$59.8K | ﹤0.01% | 3776 |
|
2021
Q1 | $315K | Sell |
15,431
-330,075
| -96% | -$6.74M | ﹤0.01% | 3580 |
|
2020
Q4 | $6.14M | Sell |
345,506
-112,537
| -25% | -$2M | ﹤0.01% | 2126 |
|
2020
Q3 | $6.77M | Sell |
458,043
-1,044,830
| -70% | -$15.4M | ﹤0.01% | 1858 |
|
2020
Q2 | $31.5M | Sell |
1,502,873
-73,842
| -5% | -$1.55M | 0.01% | 818 |
|
2020
Q1 | $36.4M | Buy |
1,576,715
+1,226,134
| +350% | +$28.3M | 0.02% | 664 |
|
2019
Q4 | $9.08M | Sell |
350,581
-69,186
| -16% | -$1.79M | ﹤0.01% | 1826 |
|
2019
Q3 | $8.18M | Sell |
419,767
-41,793
| -9% | -$814K | ﹤0.01% | 1857 |
|
2019
Q2 | $7.54M | Buy |
+461,560
| New | +$7.54M | ﹤0.01% | 1938 |
|
2016
Q4 | – | Sell |
-46,273
| Closed | -$1.68M | – | 3928 |
|
2016
Q3 | $1.68M | Buy |
+46,273
| New | +$1.68M | ﹤0.01% | 2651 |
|
2014
Q4 | – | Sell |
-1,163
| Closed | -$26K | – | 4350 |
|
2014
Q3 | $26K | Buy |
1,163
+55
| +5% | +$1.23K | ﹤0.01% | 4331 |
|
2014
Q2 | $35K | Buy |
+1,108
| New | +$35K | ﹤0.01% | 4060 |
|